1259483-19-6

Basic information

• Product Name: (S)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol dihydrogen citrate
• Synonyms: (S)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol dihydrogen citrate
• CAS NO: 1259483-19-6
• Molecular Weight: 507.605
• Mol File: 1259483-19-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol dihydrogen citrate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol dihydrogen citrate(1259483-19-6)
• EPA Substance Registry System: (S)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol dihydrogen citrate(1259483-19-6)

Safety Data

• Hazardous Substances Data: 1259483-19-6(Hazardous Substances Data)

Upstream product

• 99755-59-6 rotigotine 
• 77-92-9 citric acid 

Relevant articles and documents

A PHARMACEUTICAL COMPOSITION

The present invention relates to new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1- ol (rotigotine), their use as a medicament, for example for the treatment of CNS disorders like Parkinson Disease, RLS, fybromyalgia and/or depression, in particular through electromotive administration. The present invention relates to pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of rotigotine to at least one target tissue. The formulations are further characterized by good to excellent solubility of the salts in aqueous solutions.